|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Adamas Pharmaceuticals (NASDAQ: ADMS) through any online brokerage.
The latest price target for Adamas Pharmaceuticals (NASDAQ: ADMS) was reported by JMP Securities on October 12, 2021. The analyst firm set a price target for 0.00 expecting ADMS to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.
The stock price for Adamas Pharmaceuticals (NASDAQ: ADMS) is $8.07 last updated Tue Oct 26 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Adamas Pharmaceuticals.
Adamas Pharmaceuticals’s $Q3 earnings are confirmed for after-market on $November 8, 2021.
There is no upcoming split for Adamas Pharmaceuticals.
Adamas Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.